Clinical Trial Update: Atazanavir/Ritonavir and Zinc Pharmacokinetic Study [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating potential pharmacokinetic interaction between Atazanavir/Ritonavir and zinc in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Ritonavir (Ritonavir)
• ZINC (Zinc chloride)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 4 | Status: COMPLETED